[ad_1]
Denmark, Iceland and Norway has decided to suspend the administration of vaccines as a precautionary measure AstraZeneca – Copenhagen for 14 days, the other two countries “until further notice”, after a “suspicious death” occurred in the first country and problems were detected in the coagulation and in circulation of blood of some patients who had received batch doses Abv5300. The same one that is related in Austria in the case of a deceased woman and another hospitalized for an’embolism pulmonary after giving two doses of the vaccine, so Vienna with Estonia, Lithuania, Luxembourg and Latvia have decided to suspend drug inoculations from the batch Abv5300 – not distributed in Italy – produced byAnglo-Swedish company. Within each batch of AstraZeneca are contained on 500 thousand doses.
Draghi-Von der Leyen Telefonata – In the case of suspension of vaccines, Mario draghi I had a phone interview with Ursula Von der Leyen of which – refer to sources of Palazzo Chigi – It turned out that there is no evidence of a link between thrombosis cases in Europe and the administration of Astrazeneca. The president of the European Commission also “announced that the EMA has launched a new accelerated review” on the drug.
What happens in italy – Also in Sicily Two law enforcement officers died within days of receiving the first dose of the vaccine. AstraZeneca. In both cases the dose – as we read in the newspaper livesicilia.it – come from the same batch (ABV2856) which, however, is not the one related to the Austrian cases, because the lot ABV5300 was not distributed in Italy. A file of research. There is currently no evidence of a correlation between death and drug inoculation. what’s more Denmark, Austria, Estonia, Lithuania, Luxembourg and Latvia, the others Countries who have received vaccines from lot number ABV5300 are Bulgaria, Cipro, France, Greece, Iceland, Ireland, malt, Holland, Poland, Spain and Sweden.
Why Denmark suspended AstraZeneca – Copenhagen decided to suspend as a precautionary measure 14 days the use of the vaccine anti Covid of AstraZeneca after “reports of serious cases of blood clots among vaccinated people,” one of whom died, national health authorities reported. Clarifying that “it has not been determined, at the moment, that there is a link between the vaccine and blood clots.” The first Minister Mette Frederiksen However, he explained that it is necessary “to do more research on this point.” Suspension of the use of AstraZeneca It is scheduled for two weeks. A new evaluation will take place on March 22.
“And with to regret that we get this news And it’s too early to say what it will mean to ours road map in vaccines“Explained the premier. So much so that the end of the vaccination program has been postponed to mid-August compared to early July, as originally forecast. Denmark has administered more than 142 thousand vaccines with AstraZeneca, which is about a quarter of the population that has already received the first dose.
“We are in the middle of the largest and most important launch of vaccines in Danish history and we all need vaccines we can get our hands on so it’s not a decision easy put them on pause, “he said. Soeren Brostroem, head of the health authority. “We need to clarify before continuing to use the vaccine AstraZeneca“He added. The Danish Minister of Health Magnus heunicke However, he specified, on twitter, that it is not yet clear if the problems in the coagulation and in circulation of blood whether or not they are related to the vaccine. There decision “Follow the news of serious cases of blood clots in people vaccinated with the anti-virus vaccine. COVID-19 of AstraZeneca“Explained the Danish Health Authority in a statement, adding however that” at the moment it has not been determined that there is a link between the vaccine and blood clots. “After the decision of Copenhagen, what’s more Norway me Iceland they suspended the use of the vaccine as a precaution and until further notice AstraZeneca.
The Austrian case – On Sunday, the Austrian Federal Office for Health Security announced that it had suspended the administration of a batch of vaccines. AstraZeneca (the number ABV5300) after the death of one woman and the hospitalization of another for an’embolism pulmonary after the administration of two doses of the vaccine. L ‘MotherHowever, based on a preliminary investigation, yesterday he clarified that it was not the anti-drug COVID-19 to determine the death from the nurse. “At the moment they are not there indications that vaccination caused these terms, not listed as side effects of this vaccine, “said in a statement theEuropean Medicines Agency, also referring to the case of the other nurse hospitalized after vaccination.
Ema: “There are no greater risks of blood clots for those vaccinated” – L ‘European Medicines Agency reported that “the information available so far indicates that the number of events thromboembolic in vaccinated people it is not higher than that observed in the rest of the population. Toward March 10, 2021, 30 cases of thromboembolic events have been reported among almost 5 million people vaccinated with the vaccine. AstraZeneca in the European Economic Area “, adding that it is possible to continue using the anti-COVID-19 pending investigations into blood clots and that the Security Committee is reviewing all reported cases. “There are currently no indications that he vaccination caused these conditions, which are not listed as side effects with this vaccine. The position of the EMA safety committee (TO WASH) Is that I Benefits of the vaccine continue to outweigh its risks and the vaccine can continue to be administered while the cases of thromboembolic events are being investigated ”. For his part the Anglo-Swedish company published a short note stating that “vaccine safety” against COVID-19 “It has been studied extensively in phase 3 clinical trials and the data was submitted Peer Review confirm that, in general, the vaccine is well tolerated ”.
Even the UK, following what was decided by Denmark and from others Countries, spoke through a spokesperson for Downing street, explaining that the anti COVID-19 in question is “safe and effective” according to scientific data produced in Britain, where a total of around 23 million people have been vaccinated so far with this antidote and that produced by Pfizer. “We make it clear that it is Of course ed effective and when people are asked to take itThey must do so with confidence, ”said a spokesman for the prime minister. Boris Johnson, stressing that there is no confirmed link between the use of the vaccine AstraZeneca and cases of thrombosis.
[ad_2]
